Abstract:The development of injectable integrin alpha(v)beta(3)/alpha(IIb)beta(3) dual antagonists attracts much attention of research for treating of acute ischemic diseases in recent years. In this work, based on a dataset composed of 102 tricyclic piperazine/piperidine furnished dual alpha(v)beta(3) and alpha(IIb)beta(3) antagonists, a variety of in silico modeling approaches including the comparative molecular field analysis (CoMFA), comparative similarity indices analysis (CoMSIA), and molecular docking were applied to reveal the requisite 3D structural features impacting the biological activities. Our statistical results show that the ligand-based 3D-QSAR models for both the alpha(v)beta(3) and alpha(IIb)beta(3) studies exhibited satisfactory internal and external predictability, i.e., for the CoMFA models, results of Q(2) = 0.48, R-ncv(2) = 0.87, R-pred(2) = 0.71 for alpha(v)beta(3) and Q(2) = 0.50, R-ncv(2) = 0.85, R-pred(2) = 0.72 for alpha(IIb)beta(3) analysis were obtained, and for the CoMSIA ones, the outcomes of Q(2) = 0.55, R-ncv(2) = 0.90, R-pred(2) = 0.72 for alpha(v)beta(3) and Q(2) = 0.52, R-ncv(2) = 0.88, R-pred(2) = 0.74 for alpha(IIb)beta(3) were achieved respectively. In addition, through a comparison between 3D-QSAR contour maps and docking results, it is revealed that that the most crucial interactions occurring between the tricyclic piperazine/piperidine derivatives and alpha(v)beta(3)/alpha(IIb)beta(3) receptor ligand binding pocket are H-bonding, and the key amino acids impacting the interactions are Arg214, Asn215, Ser123, and Lys253 for alpha(v)beta(3), but Arg214, Asn215, Ser123 and Tyr190 for alpha(IIb)beta(3) receptors, respectively. Halogen-containing groups at position 15 and 16, benzene sulfonamide substituent at position 23, and the replacement of piperazine with 4-aminopiperidine of ring B may increase the alpha(v)beta(3)/alpha(IIb)beta(3) antagonistic activity. The potencies for antagonists to inhibit isolated alpha(v)beta(3) and alpha(IIb)beta(3) are linear correlated, indicating that similar interaction mechanisms may exist for the series of molecules. To our best knowledge this is the first report on 3D-QSAR modeling of these dual alpha(v)beta(3)/alpha(IIb)beta(3) antagonists. The results obtained should provide information for better understanding of the mechanism of antagonism and thus be helpful in design of novel potent dual alpha(v)beta(3)/alpha(IIb)beta(3) antagonists. (C) 2011 Elsevier Inc. All rights reserved.

Investigation on Quantitative Structure Activity Relationships and Pharmacophore Modeling of a Series of Mglur2 Antagonists

Studies of Phenylethynyl-pyrrolo[1,2-a]pyrazine as mGluR5 Antagonists Using 3D-QSAR Method

Structure-based Rational Quest for Potential Novel Inhibitors of Human HMG-CoA Reductase by Combining CoMFA 3D QSAR Modeling and Virtual Screening.

Molecular Recognition of Metabotropic Glutamate Receptor Type 1 (mglur1): Synergistic Understanding with Free Energy Perturbation and Linear Response Modeling

Profiling the Structural Determinants of Aryl Benzamide Derivatives As Negative Allosteric Modulators of Mglur5 by in Silico Study

Mechanism Exploration of Arylpiperazine Derivatives Targeting the 5-HT 2A Receptor by In Silico Methods.

Studies of H4R Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

Studies of Tricyclic Piperazine/piperidine Furnished Molecules As Novel Integrin Αvβ3/αiibβ3 Dual Antagonists Using 3D-QSAR and Molecular Docking.

Studies of New Fused Benzazepine As Selective Dopamine D3 Receptor Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

Profiling the Interaction Mechanism of Quinoline/Quinazoline Derivatives As MCHR1 Antagonists: an in Silico Method

Study of 3D-QSAR of 5-HT 6 receptor antagonists

The optimization of a novel selective antagonist for human M<sub>2</sub> muscarinic acetylcholine receptor

Atom-based 3D-QSAR, induced fit docking, and molecular dynamics simulations study of thieno[2,3-b]pyridines negative allosteric modulators of mGluR5

Quantitative Structure-Activity Relationship of 2-Alkyl-4-(biphenylylmethoxy) Pyridine Derivatives with AT1 Receptor Antagonistic Activity

Discovery of Novel Mglur1 Antagonists: a Multistep Virtual Screening Approach Based on an SVM Model and a Pharmacophore Hypothesis Significantly Increases the Hit Rate and Enrichment Factor.

Exploring Details about Structure Requirements Based on Novel Cgrp Receptor Antagonists Urethanamide, Aspartate, Succinate and Pyridine Derivatives by in Silico Methods

QSAR Studies of 2,3-Benzodiazepin-4(sulfur) ketone-related Negative Allosteric Modulators of the AMPA Receptor

Structural Features of Gaba(A) Receptor Antagonists: Pharmacophore Modeling and 3D-Qsar Studies

Molecular Modeling of the 3D Structure of 5-HT(1A)R: Discovery of Novel 5-HT(1A)R Agonists Via Dynamic Pharmacophore-Based Virtual Screening.

Study on the antagonists for the orphan G protein-coupled receptor GPR55 by quantitative structure–activity relationship

Computational Analysis of Structure-Based Interactions for Novel H₁-Antihistamines